logo

Vaccinex, Inc. (VCNX)



Trade VCNX now with
  Date
  Headline
9/22/2020 7:35:52 AM Vaccinex Says Phase 2 SIGNAL Study Does Not Meet Pre-specified Co-primary Endpoints
9/17/2020 8:13:58 AM Vaccinex Enters Clinical Collaboration Agreement With Merck To Evaluate Pepinemab And KEYTRUDA
12/10/2019 8:18:18 AM Vaccinex Reports $3 Mln Award From The Alzheimer's Drug Discovery Foundation
9/27/2019 6:13:43 AM Vaccinex Presents Updated Interim Data From Phase 1b/2 Study Of Pepinemab With Avelumab At CICON2019
3/13/2019 7:22:55 AM Vaccinex Q4 Revenue $194K Vs $90K Last Year
1/17/2019 8:33:49 AM Vaccinex Presents Data From Ongoing Phase 1/2 Trial Of VX15/2503 In Huntington’s Disease